vs

Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and Upstart Holdings, Inc. (UPST). Click either name above to swap in a different company.

Upstart Holdings, Inc. is the larger business by last-quarter revenue ($296.1M vs $151.7M, roughly 2.0× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 6.3%, a 1.5% gap on every dollar of revenue. On growth, Upstart Holdings, Inc. posted the faster year-over-year revenue change (35.2% vs -41.1%). Upstart Holdings, Inc. produced more free cash flow last quarter ($108.4M vs $69.0M). Over the past eight quarters, Upstart Holdings, Inc.'s revenue compounded faster (52.2% CAGR vs 50.0%).

Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.

Upstart is an AI lending platform that partners with banks and credit unions to provide consumer loans using non-traditional variables, such as education and employment, to predict creditworthiness.

NUTX vs UPST — Head-to-Head

Bigger by revenue
UPST
UPST
2.0× larger
UPST
$296.1M
$151.7M
NUTX
Growing faster (revenue YoY)
UPST
UPST
+76.3% gap
UPST
35.2%
-41.1%
NUTX
Higher net margin
NUTX
NUTX
1.5% more per $
NUTX
7.8%
6.3%
UPST
More free cash flow
UPST
UPST
$39.4M more FCF
UPST
$108.4M
$69.0M
NUTX
Faster 2-yr revenue CAGR
UPST
UPST
Annualised
UPST
52.2%
50.0%
NUTX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NUTX
NUTX
UPST
UPST
Revenue
$151.7M
$296.1M
Net Profit
$11.8M
$18.6M
Gross Margin
30.4%
Operating Margin
20.4%
6.4%
Net Margin
7.8%
6.3%
Revenue YoY
-41.1%
35.2%
Net Profit YoY
-80.8%
776.4%
EPS (diluted)
$2.34
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NUTX
NUTX
UPST
UPST
Q4 25
$151.7M
$296.1M
Q3 25
$267.8M
$277.1M
Q2 25
$244.0M
$257.3M
Q1 25
$211.8M
$213.4M
Q4 24
$257.6M
$219.0M
Q3 24
$78.8M
$162.1M
Q2 24
$76.1M
$127.6M
Q1 24
$67.5M
$127.8M
Net Profit
NUTX
NUTX
UPST
UPST
Q4 25
$11.8M
$18.6M
Q3 25
$55.4M
$31.8M
Q2 25
$-17.7M
$5.6M
Q1 25
$21.2M
$-2.4M
Q4 24
$61.6M
$-2.8M
Q3 24
$-8.8M
$-6.8M
Q2 24
$-364.0K
$-54.5M
Q1 24
$-364.0K
$-64.6M
Gross Margin
NUTX
NUTX
UPST
UPST
Q4 25
30.4%
Q3 25
57.8%
Q2 25
51.2%
Q1 25
55.9%
Q4 24
55.0%
Q3 24
27.8%
Q2 24
29.7%
Q1 24
15.1%
Operating Margin
NUTX
NUTX
UPST
UPST
Q4 25
20.4%
6.4%
Q3 25
48.7%
8.5%
Q2 25
13.8%
1.8%
Q1 25
38.1%
-2.1%
Q4 24
44.4%
-2.2%
Q3 24
12.3%
-27.8%
Q2 24
7.0%
-43.5%
Q1 24
2.1%
-52.8%
Net Margin
NUTX
NUTX
UPST
UPST
Q4 25
7.8%
6.3%
Q3 25
20.7%
11.5%
Q2 25
-7.3%
2.2%
Q1 25
10.0%
-1.1%
Q4 24
23.9%
-1.3%
Q3 24
-11.2%
-4.2%
Q2 24
-0.5%
-42.7%
Q1 24
-0.5%
-50.5%
EPS (diluted)
NUTX
NUTX
UPST
UPST
Q4 25
$2.34
$0.20
Q3 25
$7.76
$0.23
Q2 25
$-2.95
$0.05
Q1 25
$3.33
$-0.03
Q4 24
$11.56
$-0.01
Q3 24
$-1.72
$-0.07
Q2 24
$-0.07
$-0.62
Q1 24
$-0.08
$-0.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NUTX
NUTX
UPST
UPST
Cash + ST InvestmentsLiquidity on hand
$185.6M
$652.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$329.4M
$798.8M
Total Assets
$918.5M
$3.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NUTX
NUTX
UPST
UPST
Q4 25
$185.6M
$652.4M
Q3 25
$166.0M
$489.8M
Q2 25
$96.7M
$395.9M
Q1 25
$84.7M
$599.8M
Q4 24
$40.6M
$788.4M
Q3 24
$46.9M
Q2 24
$40.8M
Q1 24
$30.0M
Stockholders' Equity
NUTX
NUTX
UPST
UPST
Q4 25
$329.4M
$798.8M
Q3 25
$317.2M
$743.7M
Q2 25
$235.3M
$722.0M
Q1 25
$176.9M
$676.6M
Q4 24
$132.4M
$633.2M
Q3 24
$60.4M
$595.5M
Q2 24
$62.7M
$594.7M
Q1 24
$63.0M
$612.8M
Total Assets
NUTX
NUTX
UPST
UPST
Q4 25
$918.5M
$3.0B
Q3 25
$964.5M
$2.9B
Q2 25
$841.0M
$2.5B
Q1 25
$761.9M
$2.3B
Q4 24
$655.3M
$2.4B
Q3 24
$438.5M
$1.8B
Q2 24
$422.4M
$1.8B
Q1 24
$404.3M
$1.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NUTX
NUTX
UPST
UPST
Operating Cash FlowLast quarter
$70.4M
$108.6M
Free Cash FlowOCF − Capex
$69.0M
$108.4M
FCF MarginFCF / Revenue
45.5%
36.6%
Capex IntensityCapex / Revenue
0.9%
0.1%
Cash ConversionOCF / Net Profit
5.95×
5.82×
TTM Free Cash FlowTrailing 4 quarters
$245.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NUTX
NUTX
UPST
UPST
Q4 25
$70.4M
$108.6M
Q3 25
$99.5M
$-122.6M
Q2 25
$27.3M
$-120.2M
Q1 25
$51.0M
$-13.5M
Q4 24
$54.0K
$-110.9M
Q3 24
$6.8M
$179.3M
Q2 24
$13.3M
$65.3M
Q1 24
$3.1M
$52.6M
Free Cash Flow
NUTX
NUTX
UPST
UPST
Q4 25
$69.0M
$108.4M
Q3 25
$99.2M
$-122.7M
Q2 25
$26.5M
$-120.3M
Q1 25
$50.9M
Q4 24
$-341.0K
Q3 24
$6.2M
$179.2M
Q2 24
$12.7M
$65.3M
Q1 24
$2.3M
$51.9M
FCF Margin
NUTX
NUTX
UPST
UPST
Q4 25
45.5%
36.6%
Q3 25
37.0%
-44.3%
Q2 25
10.9%
-46.7%
Q1 25
24.0%
Q4 24
-0.1%
Q3 24
7.8%
110.5%
Q2 24
16.7%
51.1%
Q1 24
3.4%
40.6%
Capex Intensity
NUTX
NUTX
UPST
UPST
Q4 25
0.9%
0.1%
Q3 25
0.1%
0.0%
Q2 25
0.3%
0.0%
Q1 25
0.0%
0.0%
Q4 24
0.2%
0.0%
Q3 24
0.8%
0.1%
Q2 24
0.7%
0.0%
Q1 24
1.1%
0.5%
Cash Conversion
NUTX
NUTX
UPST
UPST
Q4 25
5.95×
5.82×
Q3 25
1.80×
-3.86×
Q2 25
-21.43×
Q1 25
2.40×
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NUTX
NUTX

Hospital Division$143.7M95%
Population Health Management Division$8.0M5%

UPST
UPST

Personal Lending Segment$201.4M68%
Servicing Fees Net$39.5M13%
Servicing Fees$27.5M9%
Other$15.7M5%
Borrower Fees$8.4M3%
Collection Agency Fees$3.5M1%

Related Comparisons